Reven’s patented treatment platform for sepsis on track for testing COVID-19 patients

Reven’s patented treatment platform for sepsis on track for testing COVID-19 patients

GOLDEN -- Reven Holdings, a privately held clinical stage biotechnology and pharmaceutical company dedicated to the discovery and development of novel treatment platforms for cancer, viral... Read More

Tuesday September 15, 2020 0 comments Tags: Golden, Reven Holdings, Reven Pharmaceuticals, COVID-19, Michael Volk, Fatih Uckun, Rejuveinix